HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Wallemacq, P. E. Articles by Hassoun, A. Search for Related Content PubMed PubMed Citation Articles by Wallemacq, P. E. Articles by Hassoun, A. Related Collections Clinical Immunology Drug Monitoring and Toxicology

IMx Tacrolimus II vs IMx Tacrolimus Microparticle Enzyme Immunoassay Evaluated in Renal and Hepatic Transplant Patients

¹ Clin. Chem.,
² Kidney Transplant., and
³ Hepatic Transplant., University Hosp. St Luc, Univ. of Louvain, 10 Hippocrate Ave., B-1200 Brussels, Belgium;
^a address for correspondence: Dept. of Clin. Chem., Lab. of Therapeutic Drug Monit., University Hosp. St Luc-U.C.L., 10 Hippocrate Ave., B-1200 Brussels, Belgium, fax +32-2-764-37-32, e-mail wallemacq@lbcm.ucl.ac.be

In 1992, an automated whole-blood microparticle enzyme immunoassay was developed (Abbott Labs.) for the measurement of tacrolimus concentrations (TAC I) on the IMx analyzer (1). This method involves the antitacrolimus monoclonal antibody developed by Fujisawa Pharmaceutical, the company producing the immunosuppressant tacrolimus (2). The assay requires 100 µL of whole blood, and 24 samples can be analyzed in ~40 min after a rapid organic extraction (200 µL of precipitation reagent: ZnSO₄ solution in methanol and ethylene glycol). The capture reagent consists of latex microparticles to which tacrolimus antibodies are attached, the enzyme is tacrolimus-conjugated alkaline phosphatase, and the substrate is 4-methylumbelliferyl phosphate. This method yields CVs of ~10% (11.8% and 9.6% at concentrations of 15 and 25 µg/L, respectively) (1), but is limited by the detection limit of 5 µg/L. Because in current clinical practice a nonnegligible percentage of transplant patients display low tacrolimus concentrations (<6 µg/L), the immunoassay has recently been modified. A new assay, IMx tacrolimus II (TAC II), with a lower detection limit, has been developed, requiring 150 µL of whole blood and 150 µL of precipitation reagent. Whereas the TAC I has a dynamic range of quantification from 5 to 60 µg/L, the TAC II assay has a range from 1 to 30 µg/L, better corresponding to the therapeutic range of tacrolimus (5–15 µg/L) (3). Because this new assay will replace the TAC I, we have evaluated and compared the two assays in terms of their analytical performances, and their correlation in clinical blood specimens obtained from kidney and liver transplant patients.

Analytical performances were evaluated on the same IMx analyzer, by the same technician, and on the same days. The pipettes used were calibrated before the study. . . . [Full Text of this Article]

Acknowledgments

References

The following articles in journals at HighWire Press have cited this article:

				C. Hartel, N. Schumacher, L. Fricke, B. Ebel, H. Kirchner, and M. Muller-Steinhardt Sensitivity of Whole-Blood T Lymphocytes in Individual Patients to Tacrolimus (FK 506): Impact of Interleukin-2 mRNA Expression as Surrogate Measure of Immunosuppressive Effect Clin. Chem., January 1, 2004; 50(1): 141 - 151. [Abstract] [Full Text] [PDF]

				Z. T. Cao, M. W. Linder, A. W. Jevans, G. Brown, and R. Valdes Jr Comparison of Tacrolimus Concentrations Measured by the IMx Tacrolimus II vs the PRO-TRAC II FK506 ELISA Assays Clin. Chem., October 1, 1999; 45(10): 1868 - 1870. [Full Text] [PDF]

				J. M. Tredger, C. D. Gilkes, and C. E. Gonde Performance of the IMx Tacrolimus II Assay and Practical Limits of Detection Clin. Chem., October 1, 1999; 45(10): 1881 - 1882. [Full Text] [PDF]

				C. M. Schambeck, A. Bedel, and F. Keller Limit of Quantification (Functional Sensitivity) of the New IMx Tacrolimus II Microparticle Enzyme Immunoassay Clin. Chem., October 1, 1998; 44(10): 2217 - 2217. [Full Text] [PDF]

				U. C. Garg, G. Austin, C. Barnes, and M. Hamilton Comparison of the Abbott IMx Tacrolimus I and Tacrolimus II Assays Clin. Chem., August 1, 1998; 44(8): 1783 - 1785. [Full Text] [PDF]